drugset / Trial / NCT02912364

Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults

NCT02912364

RandomizedCrossoverDouble-blindTreatment

Summary

Double-blind, randomized, two period crossover comparison of the cognitive and behavioral effects of Eslicarbazepine acetate and Carbamazepine in healthy volunteers.

Timeline

Start
2016-07
Primary completion
2018-04-20
Completion
2018-04-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule 400 mg Oral
Subject Eslicarbazepine acetate Unknown 800 mg Oral

Indications